Alx Oncology Holdings Stock Price Patterns
| ALXO Stock | USD 2.32 0.05 2.20% |
Momentum 66
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.33) | EPS Estimate Current Year (1.56) | EPS Estimate Next Year (0.75) | Wall Street Target Price 3.3333 | EPS Estimate Current Quarter (0.37) |
Using Alx Oncology hype-based prediction, you can estimate the value of Alx Oncology Holdings from the perspective of Alx Oncology response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Alx Oncology using Alx Oncology's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Alx using crowd psychology based on the activity and movement of Alx Oncology's stock price.
Alx Oncology Short Interest
An investor who is long Alx Oncology may also wish to track short interest. As short interest increases, investors should be becoming more worried about Alx Oncology and may potentially protect profits, hedge Alx Oncology with its derivative instruments, or be ready for some potential downside.
200 Day MA 1.1075 | Short Percent 0.0331 | Short Ratio 3.36 | Shares Short Prior Month 1.1 M | 50 Day MA 1.5317 |
Alx Oncology Holdings Hype to Price Pattern
Investor biases related to Alx Oncology's public news can be used to forecast risks associated with an investment in Alx. The trend in average sentiment can be used to explain how an investor holding Alx can time the market purely based on public headlines and social activities around Alx Oncology Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Alx Oncology's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Alx Oncology.
Alx Oncology Implied Volatility | 2.07 |
Alx Oncology's implied volatility exposes the market's sentiment of Alx Oncology Holdings stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Alx Oncology's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Alx Oncology stock will not fluctuate a lot when Alx Oncology's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Alx Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Alx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Alx Oncology after-hype prediction price | USD 2.16 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Alx Oncology Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alx Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Alx Oncology After-Hype Price Density Analysis
As far as predicting the price of Alx Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Alx Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Alx Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Alx Oncology Estimiated After-Hype Price Volatility
In the context of predicting Alx Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Alx Oncology's historical news coverage. Alx Oncology's after-hype downside and upside margins for the prediction period are 0.11 and 8.44, respectively. We have considered Alx Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Alx Oncology is dangerous at this time. Analysis and calculation of next after-hype price of Alx Oncology Holdings is based on 3 months time horizon.
Alx Oncology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Alx Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alx Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Alx Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.08 | 6.23 | 0.13 | 0.12 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.32 | 2.16 | 5.68 |
|
Alx Oncology Hype Timeline
Alx Oncology Holdings is presently traded for 2.32. The entity has historical hype elasticity of -0.13, and average elasticity to hype of competition of -0.12. Alx is anticipated to decline in value after the next headline, with the price expected to drop to 2.16. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -5.68%, whereas the daily expected return is presently at 1.08%. The volatility of related hype on Alx Oncology is about 5663.64%, with the expected price after the next announcement by competition of 2.20. About 73.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.01. Alx Oncology Holdings had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 9 days. Check out Alx Oncology Basic Forecasting Models to cross-verify your projections.Alx Oncology Related Hype Analysis
Having access to credible news sources related to Alx Oncology's direct competition is more important than ever and may enhance your ability to predict Alx Oncology's future price movements. Getting to know how Alx Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Alx Oncology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DTIL | Precision BioSciences | (0.01) | 7 per month | 0.00 | (0.15) | 5.99 | (7.57) | 15.28 | |
| RPTX | Repare Therapeutics | 0.38 | 7 per month | 1.47 | 0.11 | 3.95 | (3.26) | 35.71 | |
| GUTS | Fractyl Health Common | 0.01 | 6 per month | 0.00 | (0.07) | 11.89 | (8.44) | 85.71 | |
| ATYR | aTyr Pharma | 0.01 | 10 per month | 3.79 | 0.07 | 10.23 | (7.95) | 35.20 | |
| ARTV | Artiva Biotherapeutics Common | (0.35) | 4 per month | 7.37 | 0.06 | 8.00 | (11.11) | 118.69 | |
| ADVM | Adverum Biotechnologies | 0.00 | 8 per month | 3.70 | 0.07 | 10.34 | (6.79) | 40.97 | |
| BMEA | Biomea Fusion | (0.13) | 7 per month | 5.37 | 0 | 9.38 | (8.33) | 28.51 | |
| MGX | Metagenomi Common Stock | (0.04) | 5 per month | 0.00 | (0.14) | 6.21 | (6.21) | 18.63 | |
| IMUX | Immunic | 0.02 | 6 per month | 3.97 | 0.07 | 11.29 | (6.58) | 22.02 | |
| STRO | Sutro Biopharma | (0.99) | 7 per month | 4.68 | 0.19 | 11.87 | (7.78) | 29.10 |
Alx Oncology Additional Predictive Modules
Most predictive techniques to examine Alx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Alx using various technical indicators. When you analyze Alx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Alx Oncology Predictive Indicators
The successful prediction of Alx Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Alx Oncology Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Alx Oncology based on analysis of Alx Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Alx Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Alx Oncology's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 5.24 | 7.26 | 8.35 | 7.93 | Net Debt To EBITDA | 0.0329 | 0.004454 | 0.005122 | 0.004866 |
Pair Trading with Alx Oncology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alx Oncology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alx Oncology will appreciate offsetting losses from the drop in the long position's value.Moving against Alx Stock
| 0.72 | VCYT | Veracyte Earnings Call This Week | PairCorr |
| 0.67 | OSE | OSE Pharma SA | PairCorr |
| 0.65 | RAC | Race Oncology Earnings Call This Week | PairCorr |
| 0.59 | CDIOW | Cardio Diagnostics | PairCorr |
| 0.58 | DRMA | Dermata Therapeutics | PairCorr |
| 0.48 | VCEL | Vericel Corp Ord | PairCorr |
The ability to find closely correlated positions to Alx Oncology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alx Oncology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alx Oncology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alx Oncology Holdings to buy it.
The correlation of Alx Oncology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alx Oncology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alx Oncology Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alx Oncology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Alx Oncology Basic Forecasting Models to cross-verify your projections. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Will Biotechnology sector continue expanding? Could Alx diversify its offerings? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alx Oncology data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Alx Oncology's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alx Oncology represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Alx Oncology's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.